Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

Roche ESMO
Biotech

Roche returns to China’s Hansoh for $15B biobucks ADC pact

A year after their first antibody-drug conjugate team-up, Roche has returned to Hansoh Pharmaceutical for a mammoth $15 billion biobucks deal.
James Waldron Oct 19, 2026 7:48am
AbbVie

AbbVie’s next-gen Crohn’s combo beats Skyrizi in ph. 2 test

Oct 19, 2026 5:15am
From Scientific Hypothesis to Clinical Practice The Next Chapter for CLDN182

The next chapter of CLDN18.2-directed innovation

Brought to you by Astellas Pharma US
european euros

Nouscom bags $135M for pivotal therapeutic cancer vaccine trial

Oct 19, 2026 2:00am
Aligning drug discovery around patient benefit from the outset Connecting human insights to better decisions

Aligning drug discovery around patient benefit from the outset: Connecting human insights to better decisions

Brought to you by IQVIA Laboratories
China flag against blue sky

China looks to ban foreign acquisitions of key biotech platforms

Oct 16, 2026 10:38am